Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Free Cash Flow Generation Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Free Cash Flow Generation Index of -6.78x as of December 2024. Free cash flow of CN¥-163.10 Million represents -7% of operating cash flow (CN¥24.04 Million). See 301126 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 3 annual periods. Explore 301126 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year Free Cash Flow Generation Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For the full company profile including market capitalisation, see market cap of Hunan Dajiaweikang Pharmaceutical Indust.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.78x | CN¥-163.10 Million | CN¥24.04 Million | CN¥187.14 Million | ▲ +7.8% |
| 2023 | -7.36x | CN¥-199.57 Million | CN¥27.13 Million | CN¥226.70 Million | ▼ -1066.8% |
| 2019 | 0.76x | CN¥103.41 Million | CN¥135.91 Million | CN¥32.50 Million | — |